Join
Live feed
·
PRReleasevia Quantisnow
Agenus Inc. logo
MiNK Therapeutics Inc. logo

Agenus and Noetik Present ASCO 2026 Data Linking AI Analysis of Routine Pretreatment Tumor Pathology Images to Response and Survival with BOT+BAL in MSS Metastatic CRC

ByQuantisnow·Wall Street's wire, on your screen.
AGEN· Agenus Inc.INKT· MiNK Therapeutics Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track AGEN (Agenus Inc.), INKT (MiNK Therapeutics Inc.) and more on Quantisnow.

Agenus and Noetik Present ASCO 2026 Data Linking AI Analysis of Routine Pretreatment Tumor Pathology Images to Response and Survival with BOT+BAL in MSS Metastatic CRC | Quantisnow